Загрузка...
Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study
The development of thrombocytopenia in the setting of therapeutic anticoagulation for venous thromboembolic disease (VTE) is common in cancer patients, but guidelines for management are based on limited past data and have not been validated. In 2011, Memorial Sloan Kettering Cancer Center (MSKCC) im...
Сохранить в:
| Опубликовано в: : | J Thromb Thrombolysis |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5375964/ https://ncbi.nlm.nih.gov/pubmed/28205078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-017-1478-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|